Monash IVF GroupMNIVF 76 EV-to-FCF is 49.07 as of Jun. 27, 2026, which is 205% above its 10-year median of 16.11. GuruFocus rates MNIVF with a GF Score™ of 76/100 and a GF Value™ of $0.78. The stock has 8 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Monash IVF Group ranks worse than 74.49% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Monash IVF Group's Enterprise Value is $324.5 Mil.
Monash IVF Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $6.6 Mil. Therefore, Monash IVF Group's EV-to-FCF for today is 49.07.
The historical rank and industry rank for Monash IVF Group's EV-to-FCF or its related term are showing as below:
MNIVF'
s EV-to-FCF Range Over the Past 10 Years
Min: -331.76 Med: 16.11 Max: 59.69
Current: 46.86
During the past 12 years, the highest EV-to-FCF of Monash IVF Group was 59.69. The lowest was -331.76. And the median was 16.11.
MNIVF's EV-to-FCF is ranked worse than 74.49% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.585
vs MNIVF: 46.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Monash IVF Group (OTCPK:MNIVF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Monash IVF Group's PE Ratio (TTM) for today is calculated as:
Monash IVF Group's share price for today is $0.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Monash IVF Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.025.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Monash IVF Group EV-to-FCF Related Terms
Monash IVF Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Monash IVF Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's EV-to-FCF falls into.
Monash IVF Group's current Enterprise Value is $324.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Monash IVF Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $6.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (MNIVF) has a EV-to-FCF of 49.07 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Monash IVF Group and its competitors. This is 205% above median its historical median of 16.11. According to the industry distribution chart, Monash IVF Group ranks #73 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 74.5%.
Is Monash IVF Group's EV-to-FCF too high?
Monash IVF Group's current EV-to-FCF of 49.07 is 205% above median its 10-year median of 16.11. The Medical Diagnostics & Research industry median EV-to-FCF is 22.59. Monash IVF Group's value of 49.07 is 117.3% above this industry median. Based on the distribution chart, Monash IVF Group ranks #73 out of 98 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Monash IVF Group has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #73 out of 98 companies for EV-to-FCF. This places Monash IVF Group in the lower half of its industry. The industry median EV-to-FCF is 22.59. Monash IVF Group's value of 49.07 is 117.3% above this benchmark. While the company's 10-year median is 16.11 vs. the industry median of 22.59, Monash IVF Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.59, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Monash IVF Group's current EV-to-FCF of 49.07 is 117.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Monash IVF Group and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monash IVF Group's current EV-to-FCF is 49.07, which is 205% above median its own 10-year median of 16.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Monash IVF Group (MNIVF) has a current EV-to-FCF of 49.07. The stock's GF Value™ is $0.78, compared to a current price of $0.40 — trading 48.7% below its estimated fair value. The current EV-to-FCF is 49.07, which is 205% above median its 10-year median of 16.11 and 117.3% above the Medical Diagnostics & Research industry median of 22.59. Monash IVF Group's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Monash IVF Group (MNIVF), the current EV-to-FCF is 49.07 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (MNIVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of $0.40 is trading 48.7% below its estimated GF Value™ of $0.78.
Key valuation signals for MNIVF:
EV-to-FCF: 49.07 (205% above median its 10-year median of 16.11)
GF Value™: $0.78 vs. price of $0.40 (48.7% below fair value)
Industry Position: 117.3% above the Medical Diagnostics & Research median (#73 of 98)
No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
76GF Score
Get the complete analysis for MNIVF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNIVF has been successfully added to your 
